ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AMPE Ampio Pharmaceuticals Inc

0.62
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Ampio Pharmaceuticals Inc AMPE AMEX Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.62 10:00:00
Open Price Low Price High Price Close Price Previous Close
0.62 0.62
more quote information »

Recent News

Date Time Source Heading
04/4/202405:33PRNUSAmpio Pharmaceuticals Received Audit Opinion with Going..
26/3/202408:00PRNUSAmpio Announces Voluntary Delisting and SEC Deregistration
05/3/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
29/2/202407:49EDGAR2Form 8-K - Current report
29/2/202407:48EDGAR2Form S-8 POS - Securities to be offered to employees in..
29/2/202407:47EDGAR2Form S-8 POS - Securities to be offered to employees in..
29/2/202407:46EDGAR2Form POS AM - Post-Effective amendments for registration..
29/2/202407:45EDGAR2Form RW - Registration Withdrawal Request
16/2/202401:31EDGAR2Form 8-K - Current report
15/2/202409:45PRNUSAmpio Provides Update on Results from Pre-IND Enabling..
26/1/202408:31EDGAR2Form 8-K - Current report
26/1/202408:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
25/1/202409:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/1/202408:20EDGAR2Form 8-K - Current report
12/1/202408:15PRNUSAmpio Provides Litigation Update - Reports Settlement in..
22/12/202308:25EDGAR2Form S-1 - General form for registration of securities under..
15/11/202308:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202300:30EDGAR2Form 8-K - Current report
01/11/202300:00PRNUSAmpio Pharmaceuticals to Present at the Emerging Growth..
28/10/202305:10EDGAR2Form 8-K - Current report
07/10/202305:56EDGAR2Form 8-K - Current report
06/10/202307:30PRNUSAmpio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO..
05/10/202307:15EDGAR2Form 8-K - Current report
26/9/202323:15PRNUSAmpio Pharmaceuticals to Present at the Emerging Growth..
23/9/202306:30EDGAR2Form 8-K - Current report
19/9/202306:30EDGAR2Form S-3 - Registration statement under Securities Act of..
01/9/202306:19EDGAR2Form 8-K - Current report
31/8/202320:30PRNUSAmpio Pharmaceuticals Announces Reverse Stock Split
16/8/202306:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/8/202306:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/7/202301:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/7/202306:37EDGAR2Form 8-K - Current report
27/5/202306:40PRNUSAmpio Pharmaceuticals Announces Series D Preferred Stock..

Your Recent History

Delayed Upgrade Clock